Semmax Financial Advisors Inc. Sells 14,627 Shares of CVS Health Co. (NYSE:CVS)

Semmax Financial Advisors Inc. trimmed its position in CVS Health Co. (NYSE:CVS - Free Report) by 90.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,499 shares of the pharmacy operator's stock after selling 14,627 shares during the period. Semmax Financial Advisors Inc.'s holdings in CVS Health were worth $94,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in CVS. Pzena Investment Management LLC raised its stake in shares of CVS Health by 1.5% in the third quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator's stock valued at $825,948,000 after acquiring an additional 198,920 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of CVS Health by 2.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 12,208,668 shares of the pharmacy operator's stock valued at $767,681,000 after acquiring an additional 304,386 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of CVS Health by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,049,945 shares of the pharmacy operator's stock valued at $443,301,000 after acquiring an additional 107,977 shares during the last quarter. AQR Capital Management LLC grew its holdings in shares of CVS Health by 33.5% in the 2nd quarter. AQR Capital Management LLC now owns 5,289,788 shares of the pharmacy operator's stock valued at $310,722,000 after buying an additional 1,327,855 shares during the period. Finally, National Pension Service grew its holdings in shares of CVS Health by 17.4% in the 3rd quarter. National Pension Service now owns 2,843,402 shares of the pharmacy operator's stock valued at $178,793,000 after buying an additional 421,416 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Cantor Fitzgerald reissued a "neutral" rating and set a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. UBS Group upped their target price on shares of CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a report on Thursday, November 7th. TD Cowen increased their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a report on Monday, November 25th. Barclays reduced their price target on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research report on Thursday, November 7th. Finally, Truist Financial restated a "buy" rating and issued a $67.00 target price (down previously from $76.00) on shares of CVS Health in a research report on Wednesday, November 20th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $70.33.

CVS Health Stock Performance

Shares of NYSE CVS traded down $0.11 during midday trading on Friday, reaching $59.85. 3,947,743 shares of the stock were exchanged, compared to its average volume of 12,709,454. The firm has a 50-day simple moving average of $59.36 and a two-hundred day simple moving average of $58.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm has a market cap of $75.32 billion, a price-to-earnings ratio of 15.19, a PEG ratio of 1.02 and a beta of 0.55. CVS Health Co. has a twelve month low of $52.71 and a twelve month high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. During the same quarter in the previous year, the business earned $2.21 earnings per share. The firm's revenue was up 6.3% compared to the same quarter last year. As a group, analysts anticipate that CVS Health Co. will post 5.37 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.44%. CVS Health's dividend payout ratio (DPR) is currently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.